Myeloproliferative blood cancers as a human neuroinflammation model for development of Alzheimer’s disease: evidences and perspectives
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-2094
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Myeloproliferative blood cancers as a human neuroinflammation model for development of Alzheimer’s disease: evidences and perspectives ; volume:17 ; number:1 ; day:23 ; month:8 ; year:2020 ; pages:1-13 ; date:12.2020
Journal of neuroinflammation ; 17, Heft 1 (23.8.2020), 1-13, 12.2020
- Urheber
-
Hasselbalch, Hans C.
Skov, Vibe
Kjær, Lasse
Sørensen, Torben L.
Ellervik, Christina
Wienecke, Troels
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12974-020-01877-3
- URN
-
urn:nbn:de:101:1-2020101116312000542660
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hasselbalch, Hans C.
- Skov, Vibe
- Kjær, Lasse
- Sørensen, Torben L.
- Ellervik, Christina
- Wienecke, Troels
- SpringerLink (Online service)
Ähnliche Objekte (12)
Targeting Neuroinflammation to Treat Alzheimer’s Disease
Exercise suppresses neuroinflammation for alleviating Alzheimer’s disease
Neuroinflammation and fractalkine signaling in Alzheimer’s disease
Alzheimer’s disease: natural products as inhibitors of neuroinflammation
Neuroinflammation, Its Role in Alzheimer’s Disease and Therapeutic Strategies
Neuroinflammation in Alzheimer’s disease: insights from peripheral immune cells
Increased cysteinyl-tRNA synthetase drives neuroinflammation in Alzheimer’s disease
Naringenin ameliorates amyloid-β pathology and neuroinflammation in Alzheimer’s disease
Neuroinflammation in Alzheimer's disease wanes with age
Down’s syndrome, neuroinflammation, and Alzheimer neuropathogenesis
Serum DBI and biomarkers of neuroinflammation in Alzheimer’s disease and delirium
Nanotechnology for microglial targeting and inhibition of neuroinflammation underlying Alzheimer’s pathology
Targeting Neuroinflammation to Treat Alzheimer’s Disease
Exercise suppresses neuroinflammation for alleviating Alzheimer’s disease
Neuroinflammation and fractalkine signaling in Alzheimer’s disease
Alzheimer’s disease: natural products as inhibitors of neuroinflammation
Neuroinflammation, Its Role in Alzheimer’s Disease and Therapeutic Strategies
Neuroinflammation in Alzheimer’s disease: insights from peripheral immune cells
Increased cysteinyl-tRNA synthetase drives neuroinflammation in Alzheimer’s disease
Naringenin ameliorates amyloid-β pathology and neuroinflammation in Alzheimer’s disease
Neuroinflammation in Alzheimer's disease wanes with age
Down’s syndrome, neuroinflammation, and Alzheimer neuropathogenesis
Serum DBI and biomarkers of neuroinflammation in Alzheimer’s disease and delirium
Nanotechnology for microglial targeting and inhibition of neuroinflammation underlying Alzheimer’s pathology
Targeting Neuroinflammation to Treat Alzheimer’s Disease
Exercise suppresses neuroinflammation for alleviating Alzheimer’s disease
Neuroinflammation and fractalkine signaling in Alzheimer’s disease
Alzheimer’s disease: natural products as inhibitors of neuroinflammation
Neuroinflammation, Its Role in Alzheimer’s Disease and Therapeutic Strategies
Neuroinflammation in Alzheimer’s disease: insights from peripheral immune cells
Increased cysteinyl-tRNA synthetase drives neuroinflammation in Alzheimer’s disease
Naringenin ameliorates amyloid-β pathology and neuroinflammation in Alzheimer’s disease
Neuroinflammation in Alzheimer's disease wanes with age
Down’s syndrome, neuroinflammation, and Alzheimer neuropathogenesis
Serum DBI and biomarkers of neuroinflammation in Alzheimer’s disease and delirium